Related content

Costimulatory blockade with belatacept in clinical and experimental transplantation – a review

By Emamaullee Juliet   Toso Christian   Merani Shaheed   Shapiro AM James  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 6, 2009-06 ,pp. : 789-796

Informa Healthcare

Access to resources Recommend Favorite

T-cell co-stimulatory blockade in transplantation: two steps forward one step back!

By Riella Leonardo V   Sayegh Mohamed H  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 11, 2013-11 ,pp. : 1557-1568

Informa Healthcare

Access to resources Recommend Favorite

Biological agents in kidney transplantation: belatacept is entering the field

By Wéclawiak Hugo   Kamar Nassim   Ould-Mohamed Abdoulattif   Cardeau-Desangles Isabelle   Rostaing Lionel  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 10, 2010-10 ,pp. : 1501-1508

Informa Healthcare

Access to resources Recommend Favorite

Belatacept: a new biological agent for maintenance immunosuppression in kidney transplantation

By Arora Swati   Tangirala Bhargavi   Osadchuk Liliana   Sureshkumar Kalathil K  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 7, 2012-07 ,pp. : 965-979

Informa Healthcare

Access to resources Recommend Favorite

T cell costimulatory pathways: blockade for autoimmunity

By Najafian Nader   Khoury Samia J  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 227-236

Informa Healthcare

Access to resources Recommend Favorite